Government Aid for HIV Drugs Hit By Economy

Government Aid for HIV Drugs Hit By EconomyAn economic ideal tempest is striking state AIDS Drug Assistance Programs throughout the nation.

As of June 24, according to the National Alliance of State & Territorial AIDS Directors, 1,840 people who are unable to bear the costs of treatment were on ADAP waiting lists.

In the month of June, Florida joined 10 other states whose ADAPs have stopped up giving enrollment to new patients, NASTAD reported.

Three additional states have made their eligibility criteria stricter which also includes Arkansas and Utah, which dropped some existing ADAP clients.

New Jersey intends to apply similar cut on Aug. 1 that could take away 600 from the subsidized treatment scheme. Illinois might soon follow the steps of Georgia, which on July 1 started deferring enrollment in ADAP.

DeAnn Gruber, provisional Director of Louisiana's HIV/AIDS programs said that Louisiana stopped the enrollment procedure on July 1, however has not settled on whether it would create a waiting list.

Nationwide, ADAP enrollment multiplied by 12% from June 2008 to June 2009, just as the financial catastrophe saw a lot of people lose their jobs as well as insurance coverage.

Ten states have blocked covering treatments that do not have direct relation to HIV/AIDS. By August 1, Florida will cut 53 of 101 drugs on its ADAP formulary, some for widespread HIV-related conditions.